PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

Biotechnology

Healthcare
$1.31 +3.91%

+$0.04 today

Market cap
$69.86M
Beta
1.36
P/E (TTM)
-0.8
EPS (TTM)
-$1.47
52W Low $0.96High $1.88

Volume 1.19M

Average 0.38M

Balance Sheet

Inspect the capital base behind the business.

Assets

$116.56M

FY 2025 · Annual

-39.1% YoY

Liabilities

$11.85M

FY 2025 · Annual

-22.1% YoY

Equity

$104.71M

FY 2025 · Annual

-40.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents172.47M108.3M37.71M40.88M37.98M
Short-term Investments124.7M132.76M165.35M128.58M74.96M
Net Receivables00000
Inventory00000
Other Current Assets822K5.95M4.35M6.2M2.28M
Total Current Assets301.29M247.01M207.41M175.66M115.23M
Property, Plant & Equipment (Net)13.15M20.49M19.05M1.55M1.04M
Goodwill00000
Intangible Assets00000
Long-term Investments16.91M2.5M25.51M13.84M0
Tax Assets00000
Other Non-current Assets221K313K190K235K297K
Total Non-current Assets30.28M23.3M44.74M15.63M1.34M
Total Assets331.57M270.31M252.15M191.29M116.56M
Account Payables3.19M3M3.24M6.58M3.16M
Short-term Debt000352K0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities3.8M2.9M4.5M5.01M4.53M
Total Current Liabilities12.22M10.83M14.03M14.37M11.42M
Long-term Debt0000435K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities10.79M13.45M12.43M838K435K
Total Liabilities23.01M24.28M26.46M15.21M11.85M
Common Stock00000
Retained Earnings(167.73M)(241.04M)(310M)(368.71M)(446.45M)
Accumulated OCI(78K)(445K)224K139K84K
Other Stockholders Equity00000
Minority Interest00000
Total Equity308.56M246.03M225.69M176.08M104.71M
Total Debt11.19M13.98M13.29M1.19M838K
Net Debt(161.27M)(94.32M)(24.42M)(39.69M)(37.15M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$39.1M
Short-term Investments$54.4M
Other Current$2.2M
Total Current Assets$95.8M
PP&E (Net)$486.0K
Other Non-current$296.0K
Total Non-current Assets$782.0K
Total Assets$96.6M

Analysis

Selected assets total $96.6M for Latest. The largest visible component is Short-term Investments at $54.4M, about 56.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
3Initial statement of beneficial ownershipOct 5, 2026
8-KCurrent reportOct 5, 2026

How much cash does PMVP have?

PMV Pharmaceuticals, Inc. (PMVP) reported $37.98M in cash and equivalents in fiscal 2025.

How much debt does PMVP carry?

PMV Pharmaceuticals, Inc. (PMVP) reported $838,000.00 of total debt, with net debt of -$37.15M.